Mental Health Engagement Network (MHEN)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2011 by Lawson Health Research Institute.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborators:
London Health Sciences Centre
Canadian Mental Health Association
St. Joseph's Health Care London
Information provided by (Responsible Party):
Cheryl Forchuk, Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT01473550
First received: November 14, 2011
Last updated: NA
Last verified: November 2011
History: No changes posted
  Purpose

Patients with mood disorder or psychotic disorder will be given handheld devices with personal health records to educate, monitor and deliver customizable healthcare tools based on their personal needs. The use of technology has great potential to deliver care more effectively and efficiently. No actual information is on the handheld device - it is accessed from a secure site behind hospital firewalls.


Condition Intervention
Mood Disorder
Psychotic Disorder
Behavioral: Access to TELUS Health Space and Smart Phone

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Mental Health Engagement Network (MHEN): Connecting Clients With Their Health Team

Resource links provided by NLM:


Further study details as provided by Lawson Health Research Institute:

Primary Outcome Measures:
  • Lehman Quality of Life - Brief Version [ Time Frame: Every 6 months for total of 18 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 450
Study Start Date: November 2011
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Early Intervention
At Phase 1 (first 3 months of project), the 200 participants in Group 1 will be provided with a Personal Health Record (PHR) through TELUS Health Space, as well as they will be introduced to smart phone technology to ready them for deployment of the prompts and reminders. Two months later, they will be provided with a smart phone.
Behavioral: Access to TELUS Health Space and Smart Phone
Participants will be given their own TELUS Health Space and Smart Phone in order to have access to their personal health records. Specific procedures using the smart phone will depend on the individual care plan for each participant. Prompts and assessments will vary depending on participant needs.
Experimental: Later Intervention
A delayed implementation plan will be used (but will have no effect on the standard of care for the remaining 200 participants), so the remaining 200 participants in Group 2 will initially act as a control group, but at Phase 2 (six months later - approximately June 2012) the remaining 200 participants will be introduced to the technology in the same order (PHR -> Smart Phone). Group 2 will have the benefit of any enhancements made during Phase 1 of the project.
Behavioral: Access to TELUS Health Space and Smart Phone
Participants will be given their own TELUS Health Space and Smart Phone in order to have access to their personal health records. Specific procedures using the smart phone will depend on the individual care plan for each participant. Prompts and assessments will vary depending on participant needs.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Must be diagnosed with mood disorder or psychotic disorder for a minimum one year
  • Able to make informed consent to participate in the study
  • Able to understand and speak English to the degree necessary to participate in interviews/focus groups

Exclusion Criteria:

  • Younger than 18 or older than 80
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01473550

Contacts
Contact: Meaghan McKillop, MA 519-685-8500 ext 77098 Meaghan.McKillop@LawsonResearch.com
Contact: Amanda Kurtz, BA 519-685-8500 ext 75896 Amanda.Kurtz@lhsc.on.ca

Locations
Canada, Ontario
London Health Sciences Centre
London, Ontario, Canada, N6A5W9
Regional Mental Health Care
London, Ontario, Canada, N6A4H1
Canadian Mental Health Association (London-Middlesex Branch)
London, Ontario, Canada, N5Y4J8
Western Ontario Therapeutic Community Hostel
London, Ontario, Canada, N6B1Y6
Sponsors and Collaborators
Lawson Health Research Institute
London Health Sciences Centre
Canadian Mental Health Association
St. Joseph's Health Care London
Investigators
Principal Investigator: Cheryl Forchuk, PhD Lawson Health Research Institute; University of Western Ontario
  More Information

No publications provided

Responsible Party: Cheryl Forchuk, Assistant Director, Lawson Health Research Institute
ClinicalTrials.gov Identifier: NCT01473550     History of Changes
Other Study ID Numbers: 18451
Study First Received: November 14, 2011
Last Updated: November 14, 2011
Health Authority: Canada: Ethics Review Committee

Keywords provided by Lawson Health Research Institute:
Mental Health
Smart Technology
Mood disorder
Psychotic disorder

Additional relevant MeSH terms:
Psychotic Disorders
Mental Disorders
Mood Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on July 24, 2014